Brief: Casi Pharmaceuticals Announces Stock Repurchase Program
17/12/2021 12:09
Dec 17 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES STOCK REPURCHASE PROGRAM
* CASI PHARMACEUTICALS INC - BOARD OF DIRECTORS APPROVED A STOCK REPURCHASE
PROGRAM FOR REPURCHASE OF UP TO USD 10 MILLION OF COMPANY'S COMMON STOCK
Source text for Eikon: ID:nPn7qlpQGa
Further company coverage: CASI.O
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary